Syndax Pharmaceuticals Inc (SNDX)
EBITDA
-$36.68M
Quarterly · Period ending: · USD
SNDX EBITDA
Latest reported-$36.68Mperiod ending
Latest reported-$36.68Mperiod ending
SNDX Quarterly EBITDA (-$1.01K → -$36.68M)
Quarterly EBITDA
High-resolution chart · PNG
SNDX ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -36,682,000 | |
| -30,823,000 | |
| -15,309,000 | |
| -52,429,000 | |
| -63,934,000 | |
| -92,783,000 | |
| -89,363,000 | |
| -84,101,000 | |
| -68,015,000 | |
| -72,342,000 | |
| -72,407,000 | |
| -51,073,000 | |
| -44,577,000 | |
| -41,083,000 | |
| -39,148,000 | |
| -33,647,000 | |
| -36,866,000 | |
| -36,507,000 | |
| 96,208,000 | |
| -19,982,000 | |
| -22,267,000 | |
| -27,084,000 | |
| -19,860,000 | |
| -19,779,000 | |
| -16,402,000 | |
| -14,764,000 | |
| -13,759,000 | |
| -12,779,000 | |
| -14,916,000 | |
| -14,122,000 | |
| -18,973,000 | |
| -17,696,000 | |
| -18,876,000 | |
| -19,689,000 | |
| -19,722,000 | |
| -15,292,000 | |
| -13,769,000 | |
| -13,171,000 | |
| -11,064,000 | |
| -15,238,000 | |
| -8,630,000 | |
| -8,700,000 | |
| -6,699,000 | |
| -5,668,000 | |
| -5,025,000 | |
| -4,338,000 | |
| -3,285,000 | |
| -7,732,000 | |
| -6,321,000 | |
| -3,979,000 | |
| -2,875,000 | |
| -2,283,000 | |
| -2,095,000 | |
| -1,305,000 | |
| -1,008 |